Status:

COMPLETED

A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia

Lead Sponsor:

Janssen Pharmaceutical K.K.

Conditions:

Schizophrenia

Eligibility:

All Genders

20+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the effectiveness and safety of Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) Paliperidone compared to placebo in patients with Schiz...

Detailed Description

This is a multicenter, double blind (neither the patient nor the physician knows whether drug or placebo is being taken, or at what dosage), randomized (patients are assigned different treatments base...

Eligibility Criteria

Inclusion

  • Patients who have given their own consent in writing to participate in the study
  • Patients diagnosed with schizophrenia according to the diagnostic criteria of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 295.30, 295.10, 295.20, 295.90, 295.60)
  • Patients who have acute symptoms of schizophrenia
  • Both inpatients and outpatients are acceptable

Exclusion

  • A DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) of a mental disease diagnosis other than schizophrenia
  • A DSM-IV diagnosis of substance-related disorder (except nicotine dependence and caffeine dependence) within 180 days before the screening test
  • Total PANSS (Positive and Negative Syndrome System) score at the screening test \<70 or \>120
  • Patients treated with three or more types of antipsychotic within 28 days before the screening test
  • Parkinson's disease (except for those with drug-induced extra pyramidal symptoms)
  • Patients with a complication of or a past history of cerebrovascular accident
  • Patients with a complication of or a past history of diabetes mellitus

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

394 Patients enrolled

Trial Details

Trial ID

NCT00396565

Start Date

July 1 2006

End Date

November 1 2007

Last Update

April 29 2014

Active Locations (56)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (56 locations)

1

Aizu-Wakamatsu, Japan

2

Fujioka, Japan

3

Fujisawa, Japan

4

Fukui, Japan